Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News Why Rocket Pharmaceuticals shareholders are filing suit over adverse event risks in RP-A501 A class action lawsuit claims Rocket Pharmaceuticals misled investors about the safety and effectiveness of its gene therapy. Find out what’s at stake. byPallavi MadhirajuAugust 3, 2025